Publications
- Septic Arthritis of Facet Joint in Children: A Systematic Review and a 10-year Consecutive Case Series.
- Editorial: Innovative Approaches in the Management of Bone and Joint Infection.
- Should all patients with a culture-negative periprosthetic joint infection be treated with antibiotics? : a multicentre observational study
- Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection
- Coxiella burnetti prosthetic joint infection in an immunocompromised woman: iterative surgeries, prolonged ofloxacin‑rifampin treatment and complex reconstruction were needed for the cure
- Cost of off-label antibiotic therapy for bone and joint infections: a 6-year prospective monocentric observational cohort study in a referral centre for management of complex osteo-articular infections
- Safety of Tedizolid as Suppressive Antimicrobial Therapy for Patients With Complex Implant-Associated Bone and Joint Infection due to Multidrug-Resistant Gram-Positive Pathogens: Results From the TediSAT Cohort Study
- Novel strategies to diagnose prosthetic or native bone and joint infections
- Evaluation of intraosteoblastic activity of dalbavancin against Staphylococcus aureus in an ex vivo model of bone cell infection
- Recent progress toward the implementation of phage therapy in Western medicine
- Subcutaneous Antibiotic Therapy: The Why, How, Which Drugs and When
- The fused spine remains at risk of fracture after hardware removal: How should the implants be managed in case of late-onset infections?
- Arthroscopic « Debridement and Implant Retention » With Local Administration of Exebacase (Lysin CF-301) Followed by Suppressive Tedizolid as Salvage Therapy in Elderly Patients for Relapsing Multidrug-Resistant S. epidermidis Prosthetic Knee Infection
- Lysosomal alkalization to potentiate eradication of intra-osteoblastic Staphylococcus aureus in the bone and joint infection setting.
- Adherence to oral antibiotic therapy in patients with bone and joint infection: A pilot study
- Economic study of 2-stage exchange in patients with knee or hip prosthetic joint infection managed in a reference center in France: time to use innovative(s) intervention(s) at the time of reimplantation to reduce the risk of superinfection
- Management of prosthetic joint infections in France: a national audit to identify key situations requiring innovation and homogenization
- Pharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection
- Experience With the Use of the MicroDTTect Device for the Diagnosis of Low-Grade Chronic Prosthetic Joint Infections in a Routine Setting
- Impact on the Gut Microbiota of Intensive and Prolonged Antimicrobial Therapy in Patients With Bone and Joint Infection
- Antimicrobial activity of the new FabI inhibitor Afabicin desphosphono against intraosteoblastic Staphylococcus aureus
Posters
- CEFTAROLINE AND CEFTOBIPROLE: REAL LIFE OFF LABEL USE IN PATIENTS WITH BJI OF THESE TWO BETALACTAMS ACTIVE AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCI
- IMPLEMENTATION OF A PHAGE THERAPY CENTER IN FRANCE DEDICATED TO COMPLEX BONE AND JOINT INFECTION: 4-YEAR EXPERIENCE OF MULTIDISCIPLINARITY AND MULTISTEP INTERACTIONS
- Coût des antibiothérapies hors AMM dans les infections ostéo-articulaires : Etude prospective observationnelle sur 6 ans dans un Centre de Référence pour la prise en charge des IOA complexes (CRIOAc)
- Projet PHAGEinLYON – Traitement par phagothérapie des infections ostéo-articulaires à staphylocoques: caractérisation de dix-sept bactériophages anti-Staphylococcus
- Mise en place d’un centre de phagothérapie en France dédié aux infections ostéo-articulaires complexes : 4 ans d’expérience de multidisciplinarité et d’interactions multi-étapes
- Conception et construction d’un bâtiment dédié aux maladies infectieuses et tropicales : huit années de travail concerté pour obtenir une structure innovante et modulable en fonction du risque épidémique
- Safety of tedizolid as suppressive antimicrobial therapy for patients with complex implant-associated bone and joint infection due to multidrug-resistant Gram-positive pathogens: results from the TediSAT cohort study
- Implementation of a phage therapy center in France dedicated to complex bone and joint infection: 4-year experience of multidisciplinarity and multistep interactions
- Impact on the gut microbiota of intensive and prolonged antimicrobial therapy in patients with bone and joint infection
- Results of a collaboration between a CRPV and an infectious disease care service
- Isolation and characterization of a novel Jumbo phage active against the emerging ST307 carbapenemase-producing K. pneumoniae clone
- Targeting coagulase negative staphylococci causing prosthetic infections with bacteriophages: can we use polyvalent anti Staphylococcus phages ?
- Phage discovery: isolation and characterization of seventeen novel anti-Staphylococcus aureus bacteriophages
Ouvrages
Formation continue et webinaires
- Thérapie Phagique, Où en sommes nous ?
- Bone and joint infection Workshop
- Utilisation clinique de bactériophages
- French Periprosthetic infection Network Referral Reference Centers for the management of BJI
- Phagothérapie : une réponse à l’antibiorésistance ?
- Fagoterapia en el tratamiento de las infecciones causadas por Staphylococcus aureus ¿qué evidencia tenemos? Phage therapy in the treatment of infections caused by Staphylococcus aureus what evidence do we have?
- Phage therapy experience in France in the field of Bone and Joint Infection
- Problème difficile et ISO : Exemple des infections complexes en chirurgie orthopédique et leurs prises en charges multidisciplinaires
- Du Phage Discovery au Phagogramme
- LES PHAGES DANS LES IOA De l’historique aux indications pertinentes
- ASPECTS REGLEMENTAIRES ET PHARMACEUTIQUES DE L’UTILISATION DES BACTERIOPHAGES EN THERAPEUTIQUE
Diplôme Inter-Universitaire (DIU)
DES et DESC de Maladies Infectieuses
Communications orales
- Bacilles à Gram négatif de résistance émergente aux antibiotiques : nouveaux antibiotiques et nouvelles stratégies thérapeutiques
- Challenge de la prise en charge des infections plurimicrobiennes
- Rationnel des combinaisons d’antibiotiques dans les ciments orthopédiques pour fixer les prothèses lors des révisions septiques
- SESSION ORALE LIBRE 22/10/2021
- Place de la phagothérapie
- Place de l’antibiothérapie suppressive
- Expérience Strasbourgeoise dans le changement en 1 temps
- Expérience clinique et indications dans un centre Français
- Pharmacocinétiques et activités des antibiotiques libérés par les ciments
- Expérience clinique et indications dans un centre Belge
- Apport des nouveaux marqueurs diagnostiques et critères de Philadelphie
- Apport de l’imagerie (Scanner et IRM) pour le diagnostic d’infection sur implant
- Le diagnostic microbiologique
- SESSION ORALE LIBRE 21/10/2021 MATIN
- SESSION ORALE LIBRE 21/10/2021 APRES-MIDI
- Apport des nouveaux antibiotiques à longue demi-vie dans les infections a Gram+
- Prévention des infections des sites opératoires sur chirurgie prothétique en orthopédie : pertinence et appropriation
- Diagnostic des infections de prothèse basés sur les biomarqueurs locaux et circulants
- The Phage lysinCF-301 (Exebacase) in patients with staphylococcal prosthetic joint infection: Experience of a referral clinical center
- Bone and Joint Infections : synergistic antibiofilm effect of exebacase and antibiotics against Staphylococcus epidermidis strains
- Development of phage therapy to treat staphylococci bone and joint infections in France: isolation and characterization of seventeen novel anti Staphylococcus bacteriophages
- In patients with BJI, 6 and 12 weeks of antimicrobial therapy seems to have a similar impact on the gut microbiota and no particular antibiotic seems to impact its recovery
- Conservative management of chronic infections: Experience with subcutaneous antimicrobial suppressive treatment and bacteriophages
- French Periprosthetic infection Network : Referral / Reference Centers for the management of BJI
- Preparations & Formulations for phage therapy
- Plasma Cell Infiltration on Histopathological Samples of Chronic Bone and Joint Infections due to Cutibacterium acnes: A series of 21 cases
- Safety of Tedizolid as Suppressive Antimicrobial Therapy for Patients With Complex Implant-Associated Bone and Joint Infection due to Multidrug-Resistant Gram-Positive Pathogens: Results From the TediSAT Cohort Study
- Six Vs. 12 semaines de traitement antibiotique dans les IOA : pas de différence en terme d’impact sur le microbiote intestinal
- Goals and duties in a reference center for infections
- Sécurité du tédizolide en tant que thérapie antimicrobienne suppressive pour les patients souffrant d’une infection ostéo-articulaires complexe à Gram-positif : résultats de l’étude de cohorte TediSAT
- L’actualité en 3 patients : IOA complexe
- Actualités pharmaceutiques dans les infections ostéo-articulaires : antibiothérapie et phagothérapie
- Innovative Approach in Bone and Joint Infections: Bone Substitutes, Phages
- Clinical considerations to perform phage therapy clinical trials in patients with prothetic joint infection
Cas cliniques
- Coxiella burnetti prosthetic joint infection in an immunocompromised woman: iterative surgeries, prolonged ofloxacin‑rifampin treatment and complex reconstruction were needed for the cure
- Arthroscopic « Debridement Antibiotics and Implant Retention » With Local Injection of Personalized Phage Therapy to Salvage a Relapsing Pseudomonas Aeruginosa Prosthetic Knee Infection